Skip to main content

Morning Bell 13 April

Jessica Amir
April 13, 2021

Vaccine talks will dominate local headlines today for two reasons – the Federal government has taken the J&J vaccine off the table and ScoMo has said that Aussies will likely not receive a vaccine by the end of year.

This means travel and tourism stocks will be back in focus, in particular Qantas (ASX:QAN), as the company planned to initially resume international flights in October as Australians were initially set to be vaccinated by then.

 What to watch today:  

  • The Aussie market is expected to rise 0.2% if the futures are correct.
  • New home sales and business confidence data out today.
  • Keep an eye on the most traded stocks from yesterday. For our active trader desk, Bell Direct Advantage they were: Delorean (ASX:DEL) which listed on the ASX on Monday, and Digital Wine Ventures (ASX:DW8).

Trading ideas:

  • The a2Milk Company (ASX:A2M) was upgraded from a Hold to a Buy with an increased price target of $9.50 as China distribution is showing strong signs of early life.
  • Macquarie rated Dexus (ASX:DXS) as a Buy with a $10.33 target and an estimated dividend yield of 4.53%.
  • Galan Lithium (ASX:GLN), Mach7 Technologies (ASX:M7T), People Infrastructure (ASX:PPE) are all giving off bullish charting signals according to Trading Central.

The Spectrum Strategic Income Fund

Bell Direct
November 6, 2018

The Schroder Fixed Income Fund

Bell Direct
November 6, 2018

The Schroder Absolute Return Income Fund

Bell Direct
November 6, 2018

Market Update

Julia Lee
September 21, 2018

Equity Investor 17 September

Julia Lee
September 18, 2018

Equity Investor 10 September

Julia Lee
September 11, 2018

Equity Investor 3 September

Julia Lee
September 4, 2018

Market Update

Julia Lee
August 31, 2018

Equity Investor 27 August

Julia Lee
August 28, 2018

Market Update

Julia Lee
August 27, 2018

Market Update

Julia Lee
August 24, 2018